Why the study?
Does preparticipation cardiovascular screening effectively detect potentially lethal cardiovascular conditions in young competitive athletes?
Does preparticipation cardiovascular screening effectively detect potentially lethal cardiovascular conditions in young competitive athletes?
Preparticipation cardiovascular screening in young athletes has an exceedingly low positive predictive value due to the rarity of lethal conditions and limitations of current screening modalities.
Answers are grounded in this paper and cite their sources.
Exceedingly low PPV advises caution against routine screening reliance in athletes; leaves open validation of improved detection strategies.
Sudden cardiac death in young competitive athletes is a rare-but often highly publicized-event. Preparticipation screening for potentially lethal cardiovascular conditions is a complicated and controversial issue. Clinicians need a firm grasp of sound epidemiologic principles concerning screening programs when using the history and physical examination, echocardiography, and electrocardiography to detect potential problems. The very low prevalence of potentially lethal conditions and the low sensitivity and low specificity of the available methods of detection, used alone or in combination, render the positive predictive value of these screening methods exceedingly low.
No takes yet. Share an insight, caveat, or question.
Dennis Y. Wen (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: